WHO ICTRP trial

A study carried out on healthy volunteers to understand how COMP360 can be taken…

ISRCTN17905443 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN17905443
Public title A study carried out on healthy volunteers to understand how COMP360 can be taken in a safe and well-tolerated way
Scientific title A pharmacokinetic study with an integrated food effect arm to assess the safety, tolerability and QTcF interval following different strengths of COMP360 in healthy volunteers
Primary sponsor COMPASS Pathfinder, Ltd
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase I
Countries England;United Kingdom
Conditions Treatment-resistant depression Mental and Behavioural Disorders
Interventions In the single dose double-blind PK component of the study, 32 participants will be enrolled into 4 cohorts, with 8 participants each. Each cohort will receive a single dose of either COMP360 or a placebo capsule under fasting conditions…
Registration date Aug 8, 2024
Target size 44
Secondary IDs 2021-000011-23;Nil known;COMP 101
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations